i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis
-
Published Date:
Jan 14 2015
-
Source:Expert Rev Pharmacoecon Outcomes Res. 2015; 15(2):267-283
-
Language:English
-
Details:
-
Alternative Title:Expert Rev Pharmacoecon Outcomes Res
-
Personal Author:
-
Description:Estimates of preference-weighted health outcomes or health state utilities are needed to assess improvements in health in terms of quality-adjusted life-years. Gains in quality-adjusted life-years are used to assess the cost-effectiveness of prophylactic use of clotting factor compared with on-demand treatment among people with hemophilia, a congenital bleeding disorder. Published estimates of health utilities for people with hemophilia vary, contributing to uncertainty in the estimates of cost-effectiveness of prophylaxis. Challenges in estimating utility weights for the purpose of evaluating hemophilia treatment include selection bias in observational data, difficulty in adjusting for predictors of health-related quality of life and lack of preference-based data comparing adults with lifetime or primary prophylaxis versus no prophylaxis living within the same country and healthcare system.
-
Subject:
-
Pubmed ID:25585817
-
Pubmed Central ID:PMC4513931
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
text/xml
No Related Documents.